卡特为所有人? 商业CAR T细胞治疗的障碍,促进者和干预措施
Sofia Kaparis1, Khashayar Eshaghi2, Luca Paruzzo3
1University of Pennsylvania, Philadelphia, PA, United States.
Blood reviews
|December 25, 2025
概括
对少数群体来说,获得CAR T细胞治疗,一种革命性的癌症治疗,是不公平的. 本次审查确定了各个层面的复杂障碍,强调了需要多层次战略,以确保公平获得这种拯救生命的免疫疗法.
科学领域:
- 血液学 血液学 血液学
- 免疫治疗是一种免疫疗法.
- 健康 公平 研究 健康 公平 研究
背景情况:
- 化学抗原受体T细胞 (CAR-T) 免疫疗法在治疗血液恶性瘤方面取得了重大进展.
- 现有证据表明,在种族和少数民族群体之间,CAR T细胞疗法获得的机会存在差异.
研究的目的:
- 进行关于商业CAR-T疗法的障碍和促进者的文献范围审查.
- 确定旨在缓解获取不平等现象的干预措施,特别是针对少数群体的人口.
- 通过社会生态模型分析发现.
主要方法:
- 对37个已发表的文献来源进行范围审查.
- 由社会生态模型 (患者,提供者,机构,政策层面) 组织的分析.
- 识别与CAR-T疗法接入相关的障碍,促进者和干预措施.
主要成果:
- 阻碍CAR-T疗法获得的障碍是复杂的,存在于所有社会生态层面.
- 这些障碍对种族和少数民族人口产生了不成比例的影响.
- 在文献中,只有两项专门针对少数群体获取差异的干预措施被确定.
结论:
- 存在重大研究缺口,包括关于障碍的初级数据有限,以及缺乏患者识别的障碍.
- 通过识别障碍,促进者和干预措施,制定多层次战略对于消除获取不平等至关重要.
- 解决这些差异对于公平实施CAR-T免疫疗法至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


